Tags
- 18 Months
- A
- ACCE
- Acquire
- AI
- An
- An Ideal
- Approaches
- Artificial
- Artificial Intelligence
- Bacha
- Beyond
- Big Pharma
- Biopharmaceutical
- Biotechnology
- British
- British Columbia
- Canadian
- Cancer
- Cancer therapies
- Candidate
- Chairman
- Chemistry
- Cherkasov
- Collaboration
- Columbia
- Compound
- Database transaction
- DDR
- Detail
- Discover
- Docking
- Drug
- Drugs
- Enabling
- Enki
- Establishment
- Evaluation
- Executive
- Exercise
- Fee
- Finance
- Five
- Focus
- Following
- Foundation
- Fraction
- Horizons
- Ideal
- If
- Inhibitor
- Intelligence
- Jeffrey Bacha
- Kinase
- Laboratory
- Lead compound
- Leverage
- Maintenance, repair and operations
- Merck
- Merck & Co.
- Milestone
- Model
- Molecule
- Molecules
- New
- Next Generation
- Novel
- Opportunities
- Overlap
- Pair
- PARP
- PARP inhibitor
- Partnering
- Partnership
- Payment
- Pharma
- PHD
- Pipeline
- Platform
- Potent
- Pre-clinical development
- Professor
- Remains
- Research and development
- Rights
- Safe
- Select
- Selected
- Short
- Short list
- Small molecule
- Specific
- Start
- Strategy
- Synthesis
- Table
- Target
- Targets
- The deep
- The first
- Then
- The plan
- Therapy
- The time
- Today
- Traditional
- Twin Cinema
- University
- University of British Columbia
- Upfront
- Vague
- Variational
- Versus
- Viability